Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis

NCT00010426 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

FDA Office of Orphan Products Development

Collaborators